These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25266038)

  • 101. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects].
    Marco Igual M
    Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545
    [No Abstract]   [Full Text] [Related]  

  • 102. Brain serotonin subsystem complexity and receptor heterogeneity: therapeutic potential of selective serotonin agonists and antagonists.
    Lesch KP; Aulakh CS; Murphy DL
    Psychopharmacol Ser; 1993; 10():52-69. PubMed ID: 8361982
    [No Abstract]   [Full Text] [Related]  

  • 103. Serotonin receptors - from molecular biology to clinical applications.
    Pytliak M; Vargová V; Mechírová V; Felšöci M
    Physiol Res; 2011; 60(1):15-25. PubMed ID: 20945968
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Serotonin neuroscience discoveries usher in a new era of novel drug therapies for psychiatry.
    Stahl SM
    Psychopharmacol Bull; 1992; 28(1):3-9. PubMed ID: 1609040
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Serotonin in neurology and psychiatry].
    van Kempen GM
    Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2084-8. PubMed ID: 7477566
    [No Abstract]   [Full Text] [Related]  

  • 106. Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders.
    Fuller RW
    J Clin Psychiatry; 1986 Apr; 47 Suppl():4-8. PubMed ID: 3514585
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Multiple serotonin receptors: clinical and experimental aspects.
    Roth BL
    Ann Clin Psychiatry; 1994 Jun; 6(2):67-78. PubMed ID: 7804391
    [TBL] [Abstract][Full Text] [Related]  

  • 108. 5-HT1A partial agonists. What is their future?
    Glitz DA; Pohl R
    Drugs; 1991 Jan; 41(1):11-8. PubMed ID: 1706983
    [No Abstract]   [Full Text] [Related]  

  • 109. Serotonergic mechanisms in psychiatric disorders: new research tools, new ideas.
    Benkelfat C
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():53-6. PubMed ID: 8201247
    [No Abstract]   [Full Text] [Related]  

  • 110. Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions.
    Fuller RW
    Ann N Y Acad Sci; 1996 Mar; 780():176-84. PubMed ID: 8602731
    [No Abstract]   [Full Text] [Related]  

  • 111. Serotonin and psychiatric disorders.
    López-Ibor JJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():5-11. PubMed ID: 1484178
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Serotonin as a research platform for new drug discovery.
    Phebus LA; Schaus JM
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):941-9. PubMed ID: 10771655
    [No Abstract]   [Full Text] [Related]  

  • 113. [New therapeutic possibilities with drugs affecting serotonin receptors].
    Spigset O
    Tidsskr Nor Laegeforen; 1992 May; 112(13):1700-4. PubMed ID: 1509427
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Developmental pharmacodynamics: implications for child and adolescent psychopharmacology.
    Carrey N; Kutcher S
    J Psychiatry Neurosci; 1998 Nov; 23(5):274-6. PubMed ID: 9846031
    [No Abstract]   [Full Text] [Related]  

  • 116. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 117. [Recent advances in neuropsychopharmacology of the central serotonin receptor].
    Yamawaki S; Hayakawa H
    Yakubutsu Seishin Kodo; 1992 Apr; 12(2):43-54. PubMed ID: 1441762
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Abnormalities of serotonin metabolism and nonpsychotic psychiatric disorders.
    Csernansky JG; Sheline YI
    Ann Clin Psychiatry; 1993 Dec; 5(4):275-81. PubMed ID: 8312985
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Radioligands for the study of brain 5-HT1A receptors in vivo.
    Pike VW; Halldin C; Wikström HV
    Prog Med Chem; 2001; 38():189-247. PubMed ID: 11774795
    [No Abstract]   [Full Text] [Related]  

  • 120. [The 5-HT1A receptors: from molecular biology to neuropsychiatric symptoms].
    Navinés R; Gómez E; Gastó C
    Actas Esp Psiquiatr; 2003; 31(5):272-83. PubMed ID: 14557952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.